GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » General and Admin. Expense

Hikma Pharmaceuticals (Hikma Pharmaceuticals) General and Admin. Expense : $638 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Hikma Pharmaceuticals's General and Admin. Expense for the six months ended in Dec. 2023 was $378 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $638 Mil.


Hikma Pharmaceuticals General and Admin. Expense Historical Data

The historical data trend for Hikma Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals General and Admin. Expense Chart

Hikma Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 453.00 464.00 488.00 615.00 638.00

Hikma Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 256.00 256.00 359.00 260.00 378.00

Hikma Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $638 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hikma Pharmaceuticals General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hikma Pharmaceuticals (Hikma Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1 New Burlington Place, London, GBR, W1S 2HR
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (Hikma Pharmaceuticals) Headlines

From GuruFocus

Hikma launches generic Advair Diskus� following FDA approval

By PRNewswire PRNewswire 12-18-2020